Skip to main content
Clinical Trials/CTRI/2019/12/022200
CTRI/2019/12/022200CompletedPhase 1

Effects of exogenous melatonin on inflammatory protein (S100B) of delirium and its clinical correlation- a case control study - DELSM

King Georges Medical University0 sites73 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 1
Status
Completed
Sponsor
Enrollment
73

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 1. Diagnosis of Delirium qualifying according to ICD-10 (international classification of disease-10).
  • 2. Age 60-95 years
  • 3. Patientâ??s family members willing to give consent.

Exclusion Criteria

  • 1. Past history of seizure, ischemic or haemorrhagic CVA or traumatic brain injury and encephalitis.
  • 2. IQCODE score >= 3.5 to exclude dementia.
  • 3. Unreliable informants.

Investigators

Sponsor
King Georges Medical University

Similar Trials